Application of an immune-tolerizing procedure to generate monoclonal antibodies specific to an alternate protein isoform of bovine growth hormone
- PMID: 1489087
- DOI: 10.1016/0003-2697(92)90515-9
Application of an immune-tolerizing procedure to generate monoclonal antibodies specific to an alternate protein isoform of bovine growth hormone
Abstract
An immune-tolerizing protocol was employed to generate monoclonal antibodies to a variant protein isoform of bovine growth hormone arising from alternative pre-mRNA processing. Variant bovine growth hormone used for immunization was obtained by expression in bacteria and electroelution of the protein from preparative sodium dodecyl sulfate-polyacrylamide gels. Balb/c mice were first immunized with wild-type bovine growth hormone in the presence of the cytotoxic drug cyclophosphamide, thereby tolerizing the mouse to common epitopes shared among the two proteins. Subsequently, the mice were immunized with variant bovine growth hormone to produce antibodies specific to variant epitopes. Comparisons of fusions resulting from standard and tolerizing immunization protocols resulted in a significantly enhanced production of variant bovine growth hormone-specific antibodies as a result of the immunotolerizing protocol. The specificity of the antibodies to the variant growth hormone was substantiated by differential enzyme-linked immunosorbent assay and Western blot. Nearly all hybridomas positive for variant growth hormone were negative for wild-type growth hormone. Finally, the antibodies were used to demonstrate intracytoplasmic staining of COS I cells transiently transfected with a variant growth hormone-producing plasmid. Given the power of the polymerase chain reaction to conveniently clone alternatively processed mRNA species, followed by expression in bacteria to provide antigen, the immunotolerizing protocol provides a convenient general method for producing antibodies specific to desired protein isoforms.
Similar articles
-
Monoclonal antibodies against bovine growth hormone.Chin J Biotechnol. 1989;5(2):81-8. Chin J Biotechnol. 1989. PMID: 2491318
-
Production of monoclonal antibodies by genetic immunization.Biotechniques. 1994 Apr;16(4):616-8, 620. Biotechniques. 1994. PMID: 8024780
-
[Preparation of monoclonal antibodies against cell surface antigens in cattle].Vet Med (Praha). 1988 Mar;33(3):135-42. Vet Med (Praha). 1988. PMID: 3129855 Slovak.
-
Targeting the proteome/epitome, implementation of subtractive immunization.Biochem Biophys Res Commun. 2003 Apr 11;303(3):733-44. doi: 10.1016/s0006-291x(03)00357-7. Biochem Biophys Res Commun. 2003. PMID: 12670472 Review.
-
Theory and methods for immunization in culture and monoclonal antibody production.J Immunol Methods. 1982 Sep 30;53(3):261-91. doi: 10.1016/0022-1759(82)90175-2. J Immunol Methods. 1982. PMID: 6754815 Review. No abstract available.
Cited by
-
Increased abundance of opioid receptor heteromers after chronic morphine administration.Sci Signal. 2010 Jul 20;3(131):ra54. doi: 10.1126/scisignal.2000807. Sci Signal. 2010. PMID: 20647592 Free PMC article.
-
G-protein-coupled heteromers: regulation in disease.Methods Enzymol. 2013;521:219-38. doi: 10.1016/B978-0-12-391862-8.00012-0. Methods Enzymol. 2013. PMID: 23351742 Free PMC article.
-
AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II.EMBO J. 2011 May 3;30(12):2350-63. doi: 10.1038/emboj.2011.139. EMBO J. 2011. PMID: 21540834 Free PMC article.
-
Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and function.Front Pharmacol. 2014 Dec 3;5:268. doi: 10.3389/fphar.2014.00268. eCollection 2014. Front Pharmacol. 2014. PMID: 25520661 Free PMC article. Review.
-
Immune-tolerizing procedure for preparation of monoclonal antibodies against glycoprotein E of Pseudorabies virus.Monoclon Antib Immunodiagn Immunother. 2013 Feb;32(1):21-5. doi: 10.1089/mab.2012.0068. Monoclon Antib Immunodiagn Immunother. 2013. PMID: 23600501 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources